These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 32509782)
21. The Combination of Radiation with PARP Inhibition Enhances Senescence and Sensitivity to the Senolytic, Navitoclax, in Triple Negative Breast Tumor Cells. Softah A; Alotaibi MR; Alhoshani AR; Saleh T; Alhazzani K; Almutairi MM; AlRowis R; Alshehri S; Albekairy NA; Harada H; Boyd R; Chakraborty E; Gewirtz DA; As Sobeai HM Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002066 [TBL] [Abstract][Full Text] [Related]
22. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice. Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809 [TBL] [Abstract][Full Text] [Related]
23. Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primates. Greenberg EF; Voorbach MJ; Smith A; Reuter DR; Zhuang Y; Wang JQ; Wooten DW; Asque E; Hu M; Hoft C; Duggan R; Townsend M; Orsi K; Dalecki K; Amberg W; Duggan L; Knight H; Spina JS; He Y; Marsh K; Zhao V; Ybarra S; Mollon J; Fang Y; Vasanthakumar A; Westmoreland S; Droescher M; Finnema SJ; Florian H Heliyon; 2024 Aug; 10(16):e36483. PubMed ID: 39253182 [TBL] [Abstract][Full Text] [Related]
24. The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Hambright WS; Mu X; Gao X; Guo P; Kawakami Y; Mitchell J; Mullen M; Nelson AL; Bahney C; Nishimura H; Hellwinkel J; Eck A; Huard J J Osteoporos; 2023; 2023():5572754. PubMed ID: 36875869 [TBL] [Abstract][Full Text] [Related]
25. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss. Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947 [TBL] [Abstract][Full Text] [Related]
26. The senolytic drug ABT-263 accelerates ovarian aging in older female mice. Xia X; Yang Y; Liu P; Chen L; Dai X; Xue P; Wang Y Sci Rep; 2024 Oct; 14(1):23178. PubMed ID: 39369073 [TBL] [Abstract][Full Text] [Related]
27. Senolytic controls bone marrow mesenchymal stem cells fate improving bone formation. Zhang D; Yu K; Yang J; Xie S; Yang J; Tan L Am J Transl Res; 2020; 12(6):3078-3088. PubMed ID: 32655832 [TBL] [Abstract][Full Text] [Related]
28. An unbiased proteomics approach to identify the senescence-associated secretory phenotype of human bone marrow-derived mesenchymal stem cells. Samsonraj RM; Law SF; Chandra A; Pignolo RJ Bone Rep; 2023 Jun; 18():101674. PubMed ID: 36994454 [TBL] [Abstract][Full Text] [Related]
29. Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton. Doolittle ML; Saul D; Kaur J; Rowsey JL; Vos SJ; Pavelko KD; Farr JN; Monroe DG; Khosla S Nat Commun; 2023 Jul; 14(1):4587. PubMed ID: 37524694 [TBL] [Abstract][Full Text] [Related]
30. Elimination of senescent cells by treatment with Navitoclax/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain. Gulej R; Nyúl-Tóth Á; Ahire C; DelFavero J; Balasubramanian P; Kiss T; Tarantini S; Benyo Z; Pacher P; Csik B; Yabluchanskiy A; Mukli P; Kuan-Celarier A; Krizbai IA; Campisi J; Sonntag WE; Csiszar A; Ungvari Z Geroscience; 2023 Oct; 45(5):2983-3002. PubMed ID: 37642933 [TBL] [Abstract][Full Text] [Related]
31. The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies. Toutfaire M; Bauwens E; Debacq-Chainiaux F Biochem Pharmacol; 2017 Oct; 142():1-12. PubMed ID: 28408343 [TBL] [Abstract][Full Text] [Related]
32. Treatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortality. Karnewar S; Karnewar V; Shankman LS; Owens GK bioRxiv; 2023 Jul; ():. PubMed ID: 37502944 [TBL] [Abstract][Full Text] [Related]
34. Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling. Xu W; Zhao T; Chen H; Huang N; Gong H; Zhang J; Yang Y; Li T; Zhang G; Gong C; Yang M; Xiao H Biochem Pharmacol; 2022 Jun; 200():115045. PubMed ID: 35439535 [TBL] [Abstract][Full Text] [Related]
35. Transplantation of osteoporotic bone marrow stromal cells rejuvenated by the overexpression of SATB2 prevents alveolar bone loss in ovariectomized rats. Xu R; Fu Z; Liu X; Xiao T; Zhang P; Du Y; Yuan H; Cheng J; Jiang H Exp Gerontol; 2016 Nov; 84():71-79. PubMed ID: 27599698 [TBL] [Abstract][Full Text] [Related]
36. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice. Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116 [TBL] [Abstract][Full Text] [Related]
37. Bone Marrow Stress Decreases Osteogenic Progenitors. Ng AH; Baht GS; Alman BA; Grynpas MD Calcif Tissue Int; 2015 Nov; 97(5):476-86. PubMed ID: 26220824 [TBL] [Abstract][Full Text] [Related]
38. Controlled induction and targeted elimination of p16 Sessions GA; Copp ME; Liu JY; Sinkler MA; D'Costa S; Diekman BO FASEB J; 2019 Nov; 33(11):12364-12373. PubMed ID: 31408372 [TBL] [Abstract][Full Text] [Related]
39. Inhibiting uptake of extracellular vesicles derived from senescent bone marrow mesenchymal stem cells by muscle satellite cells attenuates sarcopenia. Dai H; Zheng W; Luo J; Yu G; Song C; Wu Y; Xu J J Orthop Translat; 2022 Jul; 35():23-36. PubMed ID: 35846725 [TBL] [Abstract][Full Text] [Related]
40. Attenuation of intrinsic ageing of the skin via elimination of senescent dermal fibroblasts with senolytic drugs. Kim H; Jang J; Song MJ; Kim G; Park CH; Lee DH; Lee SH; Chung JH J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1125-1135. PubMed ID: 35274377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]